Perimenopause vs Coeliac Disease: How to Tell the Overlapping Symptoms Apart

An Underrecognised Diagnostic Overlap

Perimenopause and coeliac disease share a surprisingly extensive list of symptoms, and both are conditions that tend to be underdiagnosed or misattributed in women in midlife. Coeliac disease is an autoimmune condition triggered by gluten consumption, in which the immune system attacks the small intestinal lining, impairing nutrient absorption. It can develop at any age, including during the perimenopausal years, and it is estimated that over 80 percent of people with coeliac disease in the UK remain undiagnosed. Women are more commonly affected than men. The hormonal changes of perimenopause can themselves trigger or worsen autoimmune activity, meaning the two conditions can emerge simultaneously. Both produce fatigue, digestive symptoms, brain fog, mood disturbance, and bone density loss. A woman in her mid-40s experiencing these symptoms may be told everything is perimenopause when coeliac disease is present and untreated. The distinction matters enormously because untreated coeliac disease causes progressive intestinal damage and long-term complications including osteoporosis, anaemia, and increased cancer risk.

Fatigue: Hormonal Versus Malabsorptive

Fatigue is central to both conditions but arises from different mechanisms. Perimenopausal fatigue is primarily driven by sleep disruption from night sweats, the neurological effects of fluctuating oestrogen and progesterone on energy regulation, and sometimes thyroid dysfunction that runs concurrent with hormonal change. It tends to fluctuate with the hormonal cycle and may improve markedly after good sleep or on days when symptoms are quieter. Fatigue from coeliac disease is rooted in malabsorption. When the intestinal villi are damaged by the immune response to gluten, absorption of iron, B12, folate, vitamin D, zinc, and other nutrients is impaired. Iron-deficiency anaemia and B12 deficiency are major causes of fatigue in undiagnosed coeliac disease and can be profound, producing breathlessness, pallor, and cognitive slowing alongside exhaustion. Unlike perimenopausal fatigue, coeliac fatigue often does not improve with rest and is not cyclical. A key differentiator is whether blood tests reveal anaemia or specific nutritional deficiencies alongside the fatigue, which would point strongly toward a malabsorptive cause.

Digestive Symptoms: What Differs

Digestive symptoms are one of the clearest differentiators, though both conditions can produce bloating, which complicates things. Perimenopause is associated with bloating, particularly in the luteal phase before a period, driven by progesterone's effect on gut motility and fluid retention. Digestive changes in perimenopause tend to be linked to the hormonal cycle and may vary noticeably across the month. The gut microbiome also shifts with hormonal changes, contributing to altered motility and food sensitivities. Coeliac disease produces gastrointestinal symptoms that are triggered specifically by gluten consumption, including bloating, abdominal cramping, diarrhoea, and in some cases constipation. Importantly, these symptoms appear after eating gluten-containing foods and improve or resolve on a gluten-free diet. Some adults with coeliac disease, particularly those diagnosed later in life, have silent or atypical presentations with few or no obvious gut symptoms, making the condition even harder to identify without specific testing. If bloating is severe, persistent, and linked to bread, pasta, and other wheat-containing foods rather than to your hormonal cycle, coeliac testing is warranted.

Brain Fog, Mood, and Cognitive Changes

Both conditions are associated with cognitive symptoms that can be difficult to distinguish by description alone. Perimenopausal brain fog is well documented and linked to oestrogen's role in supporting memory, processing speed, and verbal fluency. The cognitive changes often improve with HRT or as women adapt to the hormonal transition. Mood instability, anxiety, and low mood arise from oestrogen and progesterone's modulation of serotonin, GABA, and dopamine pathways. In coeliac disease, cognitive symptoms including difficulty concentrating, memory problems, and low mood are increasingly recognised as manifestations of gluten exposure, sometimes even in the absence of significant gut symptoms. The mechanism is not fully understood but may involve intestinal permeability, systemic inflammation, and direct neurological effects of gluten in susceptible individuals. A subset of people with coeliac disease experience a phenomenon called gluten ataxia or gluten-related neurological symptoms, though cognitive fog is more common. Mood disorders including anxiety and depression occur at higher rates in coeliac disease before diagnosis and often improve substantially on a strict gluten-free diet. If low mood or anxiety is severe and does not respond to typical perimenopause management, coeliac testing adds useful information.

Bone Density: A Shared Long-Term Risk

Both perimenopause and untreated coeliac disease are independent risk factors for osteoporosis, and the combination is particularly concerning. Oestrogen is critical for maintaining bone density, and its decline during perimenopause accelerates bone resorption, particularly in the first few years after the final menstrual period. This is why bone density monitoring and strategies to protect skeletal health are a standard part of perimenopause care. Untreated coeliac disease also causes bone density loss through a different mechanism: malabsorption of calcium and vitamin D, both of which are essential for bone mineralisation. Intestinal damage impairs absorption of these nutrients even when dietary intake is adequate, and prolonged malabsorption leads to progressive bone loss independent of oestrogen status. Women with coeliac disease have significantly higher rates of fracture than age-matched controls. A woman entering perimenopause with undiagnosed coeliac disease faces additive bone loss from both hormonal and malabsorptive pathways. DEXA scanning to assess bone density is important for both groups, and if bone loss is greater than expected for a woman's hormonal stage, coeliac disease should be included in the differential diagnosis.

Testing and When to Ask Your Doctor